|
PSMA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.795700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.115800E-01 |
| Normal-vs-Stage2 |
4.121200E-01 |
| Normal-vs-Stage3 |
1.264990E-01 |
| Normal-vs-Stage4 |
9.615700E-03 |
| Stage1-vs-Stage2 |
8.346200E-01 |
| Stage1-vs-Stage3 |
2.612600E-01 |
| Stage1-vs-Stage4 |
2.597800E-01 |
| Stage2-vs-Stage3 |
5.700000E-01 |
| Stage2-vs-Stage4 |
3.893400E-01 |
| Stage3-vs-Stage4 |
7.316600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.056000E-02 |
| Normal-vs-AfricanAmerican |
3.433000E-01 |
| Normal-vs-Asian |
2.955400E-01 |
| Caucasian-vs-AfricanAmerican |
6.320600E-01 |
| Caucasian-vs-Asian |
3.943600E-01 |
| AfricanAmerican-vs-Asian |
3.601400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.003600E-01 |
| Normal-vs-Female |
1.999740E-03 |
| Male-vs-Female |
5.999000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.190000E-01 |
| Normal-vs-Extreme_Weight |
2.333200E-01 |
| Normal-vs-Obese |
2.096200E-01 |
| Normal-vs-Extreme_Obese |
3.492200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.088800E-01 |
| Normal_Weight-vs-Obese |
6.244800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.215830E-01 |
| Extreme_Weight-vs-Obese |
8.735000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.701030E-01 |
| Obese-vs-Extreme_Obese |
1.556800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.522400E-02 |
| Normal-vs-Age(41-60Yrs) |
8.715600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.763600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.822610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.520620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.700620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.900500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.981600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.244000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.299220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.936410E-01 |
| Normal-VS-Type2 PRCC |
1.610840E-01 |
| Normal-VS-KIRP CIMP |
1.177050E-03 |
| Normal-VS-Unclassified PRCC |
1.940030E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.416000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.718220E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.159400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.109780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.284800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.253600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.263800E-01 |
| Normal-vs-N1 |
4.845600E-02 |
| Normal-vs-N2 |
5.069200E-01 |
| N0-vs-N1 |
1.439380E-01 |
| N0-vs-N2 |
3.520000E-01 |
| N1-vs-N2 |
8.727200E-01 |
|
|
